# Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)

> **NCT07272889** · PHASE1 · COMPLETED · sponsor: **Atea Pharmaceuticals, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** Ethinyl Estradioll/Levonorgestrel (EE/LNG)
- **DRUG:** Bemnifosbuvir/Ruzasvir (BEM/RZR)
- **DRUG:** Bemnifosbuvir/Ruzasvir (BEM/RZR) + Ethinyl Estradioll/Levonorgestrel (EE/LNG)

## Key facts

- **NCT ID:** NCT07272889
- **Lead sponsor:** Atea Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-12-04
- **Primary completion:** 2026-02-17
- **Final completion:** 2026-02-17
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07272889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07272889, "Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07272889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*